Deals of the day-Mergers and acquisitions

Shurgard Self Storage

11/04/2024 10:57

April 11 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 0930 GMT on
Thursday:

    ** Blackstone  BX.N  and CVC are among a list of potential
bidders for European festivals organiser Superstruct
Entertainment, several sources with knowledge of the situation
told Reuters.
     urn:newsml:reuters.com:*:nL5N3GJ26Z
    
    ** Societe Generale  SOGN.PA  has agreed to sell a
professional equipment financing business to French rival BPCE
for 1.1 billion euros ($1.18 billion) as part of a wider
divestment strategy, lifting its shares by more than 3%.
     urn:newsml:reuters.com:*:nL2N3GK0L3
    
    ** Novartis  NOVN.S  said that its tender offer for
MorphoSys has begun, with an offer price of 68 euros ($73.08)
per share in cash, corresponding to a premium of 142% on the
volume-weighted average price during the last three months.
     urn:newsml:reuters.com:*:nL5N3GK1PK
    
    ** Rhone Energies, a consortium of commodity trader
Trafigura and Entara LLC, is in exclusive negotiations with
Exxon Mobil's ESSO SAF  ESSF.PA  to acquire the Fos-sur-Mer
refinery in southern France and the Toulouse and Villette de
Vienne terminals.
     urn:newsml:reuters.com:*:nL2N3GK0HB
    
    ** European self-storage company Shurgard  SHUR.BR  has
agreed to buy UK-listed rival Lok'nStore  LOK.L  in an all-cash
deal worth 378 million pounds ($474 million) to expand in
markets beyond London, the companies said in a joint statement.
     urn:newsml:reuters.com:*:nL2N3GK0DF

    ** The U.S. Department of Justice has opened an in-depth
antitrust investigation into Nippon Steel's  5401.T  $14.1
billion takeover of U.S. Steel  X.N , the Politico reported on
Wednesday citing two people with direct knowledge of the matter.
     urn:newsml:reuters.com:*:nL3N3GJ40L
    
    ** Vertex Pharmaceuticals  VRTX.O  will buy Alpine Immune
Sciences  ALPN.O  for about $4.9 billion in cash, gaining access
to the biotech firm's treatment for an autoimmune disease of the
kidney, the companies said on Wednesday.
     urn:newsml:reuters.com:*:nL3N3GJ3TM

 (Compiled by Rajarshi Roy and Anuja Bharat Mistry in Bengaluru)
 ((AnujaBharat.Mistry@thomsonreuters.com))